Epidemiological trends of urinary tract infections, urolithiasis and benign prostatic hyperplasia in 203 countries and territories from 1990 to 2019

Cong Zhu; Dan-Qi Wang; Hao Zi; Qiao Huang; Jia-Min Gu; Lu-Yao Li; Xing-Pei Guo; Fei Li; Cheng Fang; Xiao-Dong Li; Xian-Tao Zeng

doi:10.1186/s40779-021-00359-8

Your Location：

Home >

Browse articles >

Epidemiological trends of urinary tract infections, urolithiasis and benign prostatic hyperplasia in 203 countries and territories from 1990 to 2019

RESEARCH | Updated：2023-02-28

- Epidemiological trends of urinary tract infections, urolithiasis and benign prostatic hyperplasia in 203 countries and territories from 1990 to 2019
- Military Medical Research Vol. 9, Issue 4, Pages: 432-443(2022)
- Affiliations：
  
  1.Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
  2.Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
  3.Department of Evidence-Based Medicine and Clinical Epidemiology, Second School of Clinical Medicine, Wuhan University, Wuhan 430071, China
  4.Institutes of Evidence-Based Medicine and Knowledge Translation, Henan University, Kaifeng 475000, Henan, China
  5.Department of Urology, Huaihe Hospital of Henan University, Kaifeng 475000, Henan, China
- Author bio：
  
  * vitsippa@whu.edu.cn;
  hndxhhyylxd@126.com;
  zengxiantao1128@whu.edu.cn; zengxiantao1128@163.com
- Funds：
- DOI：10.1186/s40779-021-00359-8
  CLC：
- Published：2022-08
- Accepted：
Scan QR Code
Zhu C, Wang DQ, Zi H, Huang Q, Gu JM, Li LY, et al. Epidemiological trends of urinary tract infections, urolithiasis and benign prostatic hyperplasia in 203 countries and territories from 1990 to 2019. Mil Med Res. 2021;8(1):64.
DOI：

Zhu C, Wang DQ, Zi H, Huang Q, Gu JM, Li LY, et al. Epidemiological trends of urinary tract infections, urolithiasis and benign prostatic hyperplasia in 203 countries and territories from 1990 to 2019. Mil Med Res. 2021;8(1):64. DOI： 10.1186/s40779-021-00359-8.

摘要

Abstract

Background:

Urinary tract infections (UTI)

urolithiasis

and benign prostatic hyperplasia (BPH) are three of the most common nonmalignant conditions in urology. However

there is still a lack of comprehensive and updated epidemiological data. This study aimed to investigate the disease burden of UTI

urolithiasis

and BPH in 203 countries and territories from 1990 to 2019.

Methods:

Data were extracted from the Global Burden of Disease 2019

including incident cases

deaths

disability-adjusted life-years (DALYs) and corresponding age-standardized rate (ASR) from 1990 to 2019. Estimated annual percentage changes (EAPC) were calculated to evaluate the trends of ASR. The associations between disease burden and social development degrees were analyzed using a sociodemographic index (SDI).

Results:

Compared with 1990

the incident cases of UTI

urolithiasis

and BPH increased by 60.40%

48.57%

and 105.70% in 2019

respectively. The age-standardized incidence rate (ASIR) of UTI increased (EAPC=0.08)

while urolithiasis (EAPC=–0.83) and BPH (EAPC=–0.03) decreased from 1990 to 2019. In 2019

the age-standardized mortality rate (ASMR) of UTI and urolithiasis were 3.13/100

000 and 0.17/100

000

respectively. BPH had the largest increase (110.56%) in DALYs in the past three decades

followed by UTI (68.89%) and urolithiasis (16.95%). The burden of UTI was mainly concentrated in South Asia and Tropical Latin America

while the burden of urolithiasis and BPH was recorded in Asia and Eastern Europe. Moreover

the ASIR and SDI of urolithiasis in high-SDI regions from 1990 to 2019 were negatively correlated

while the opposite trend was seen in low-SDI regions. In 2019

the ASIR of UTI in females was 3.59 times that of males

while the ASIR of urolithiasis in males was 1.96 times higher than that in females. The incidence was highest in the 30–34

55–59

and 65–69 age groups among the UTI

urolithiasis

and BPH groups

respectively.

Conclusions:

Over the past three decades

the disease burden has increased for UTI but decreased for urolithiasis and BPH. The allocation of medical resources should be based more on the epidemiological characteristics and geographical distribution of diseases.

关键词

Keywords

references

Flores-Mireles AL , Walker JN , Caparon M , Hultgren SJ . Urinary tract infections: epidemiology, mechanisms of infection and treatment options . Nat Rev Microbiol . 2015 ; 13 ( 5 ): 269 - 84 .

Lee SWH , Chan EMC , Lai YK . The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis . Sci Rep . 2017 ; 7 ( 1 ): 7984 .

Yang Y , Deng Y , Wang Y . Major geogenic factors controlling geographical clustering of urolithiasis in China . Sci Total Environ . 2016 ; 571 : 1164 - 71 .

Sánchez-Martín FM , Millán Rodríguez F , Esquena Fernández S , Segarra Tomás J , Rousaud Barón F , Martínez-Rodríguez R , et al . Incidence and prevalence of published studies about urolithiasis in Spain: a review . Actas Urol Esp . 2007 ; 31 ( 5 ): 511 - 20 .

Lee MC , Bariol SV . Changes in upper urinary tract stone composition in Australia over the past 30 years . BJU Int . 2013 ; 112 ( Suppl 2 ): 65 - 8 .

Ghani KR , Roghmann F , Sammon JD , Trudeau V , Sukumar S , Rahbar H , et al . Emergency department visits in the United States for upper urinary tract stones: trends in hospitalization and charges . J Urol . 2014 ; 191 ( 1 ): 90 - 6 .

Raheem OA , Khandwala YS , Sur RL , Ghani KR , Denstedt JD . Burden of urolithiasis: trends in prevalence, treatments, and costs . Eur Urol Focus . 2017 ; 3 ( 1 ): 18 - 26 .

GBD 2019 Diseases and Injuries Collaborators . Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 . Lancet . 2020 ; 396 ( 10258 ): 1204 - 22 .

Hankey BF , Ries LA , Kosary CL , Feuer EJ , Merrill RM , Clegg LX , et al . Partitioning linear trends in age-adjusted rates . Cancer Causes Control . 2000 ; 11 ( 1 ): 31 - 5 .

Hsueh PR , Hoban DJ , Carmeli Y , Chen SY , Desikan S , Alejandria M , et al . Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region . J Infect . 2011 ; 63 ( 2 ): 114 - 23 .

Lu PL , Liu YC , Toh HS , Lee YL , Liu YM , Ho CM , et al . Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009–2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) . Int J Antimicrob Agents . 2012 ; 40 ( Suppl ): S37 - 43 .

Gharbi M , Drysdale JH , Lishman H , Goudie R , Molokhia M , Johnson AP , et al . Antibiotic management of urinary tract infection in elderly patients in primary care and its association with bloodstream infections and all cause mortality: population based cohort study . BMJ . 2019 ; 364 : l525 .

Chant C , Smith OM , Marshall JC , Friedrich JO . Relationship of catheter-associated urinary tract infection to mortality and length of stay in critically ill patients: a systematic review and meta-analysis of observational studies . Crit Care Med . 2011 ; 39 ( 5 ): 1167 - 73 .

Brun-Buisson C , Meshaka P , Pinton P , Vallet B . EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units . Intensive Care Med . 2004 ; 30 ( 4 ): 580 - 8 .

Veneziano D , Ploumidis A , Proietti S , Tokas T , Kamphuis G , Tripepi G , et al . Evolution and uptake of the endoscopic stone treatment step 1(EST-s1) protocol: establishment, validation, and assessment in a collaboration by the European School of Urology and the Uro-Technology and Urolithiasis Sections . Eur Urol . 2018 ; 74 ( 3 ): 401 - 2 .

Dhondup T , Kittanamongkolchai W , Vaughan LE , Mehta RA , Chhina JK , Enders FT , et al . Risk of ESRD and mortality in kidney and bladder stone formers . Am J Kidney Dis . 2018 ; 72 ( 6 ): 790 - 7 .

Speakman M , Kirby R , Doyle S , Ioannou C . Burden of male lower urinary tract symptoms(LUTS) suggestive of benign prostatic hyperplasia(BPH)-focus on the UK . BJU Int . 2015 ; 115 ( 4 ): 508 - 19 .

Launer BM , McVary KT , Ricke WA , Lloyd GL . The rising worldwide impact of benign prostatic hyperplasia . BJU Int . 2021 ; 127 ( 6 ): 722 - 8 .

Pitout JD . Extra-intestinal pathogenic escherichia coli: a combination of virulence with antibiotic resistance . Front Microbiol . 2012 ; 3 : 9 .

Kahlmeter G , Poulsen HO . Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited . Int J Antimicrob Agents . 2012 ; 39 ( 1 ): 45 - 51 .

Cek M , Tandoğdu Z , Wagenlehner F , Tenke P , Naber K , Bjerklund-Johansen TE . Healthcare-associated urinary tract infections in hospitalized urological patients—a global perspective: results from the GPIU studies 2003–2010 . World J Urol . 2014 ; 32 ( 6 ): 1587 - 94 .

Sanchez GV , Babiker A , Master RN , Luu T , Mathur A , Bordon J . Antibiotic resistance among urinary isolates from female outpatients in the United States in 2003 and 2012 . Antimicrob Agents Chemother . 2016 ; 60 ( 5 ): 2680 - 3 .

Choe HS , Lee SJ , Cho YH , Çek M , Tandoğdu Z , Wagenlehner F , et al . Aspects of urinary tract infections and antimicrobial resistance in hospitalized urology patients in Asia: 10-year results of the Global Prevalence Study of Infections in Urology(GPIU) . J Infect Chemother . 2018 ; 24 ( 4 ): 278 - 83 .

Tandogdu Z , Kakariadis ETA , Naber K , Wagenlehner F , Bjerklund-Johansen TE . Appropriate empiric antibiotic choices in health care associated urinary tract infections in urology departments in Europe from 2006 to 2015: a Bayesian analytical approach applied in a surveillance study . PLoS One . 2019 ; 14 ( 4 ): e0214710 .

Howard P , Pulcini C , Levy Hara G , West RM , Gould IM , Harbarth S , et al . An international cross-sectional survey of antimicrobial stewardship programmes in hospitals . J Antimicrob Chemother . 2015 ; 70 ( 4 ): 1245 - 55 .

Foxman B , Brown P . Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs . Infect Dis Clin North Am . 2003 ; 17 ( 2 ): 227 - 41 .

Dielubanza EJ , Schaeffer AJ . Urinary tract infections in women . Med Clin North Am . 2011 ; 95 ( 1 ): 27 - 41 .

Gupta K , Grigoryan L , Trautner B . Urinary tract infection . Ann Intern Med . 2017 ; 167 ( 7 ): 49 - 64 .

Hooton TM . Pathogenesis of urinary tract infections: an update . J Antimicrob Chemother . 2000 ; 46 ( Suppl 1 ): 1–7; discussion 63–5 .

Walker V , Stansbridge EM , Griffin DG . Demography and biochemistry of 2800 patients from a renal stones clinic . Ann Clin Biochem . 2013 ; 50 ( Pt 2 ): 127 - 39 .

Lieske JC , Peña de la Vega LS , Slezak JM , Bergstralh EJ , Leibson CL , Ho KL , et al . Renal stone epidemiology in Rochester, Minnesota: an update . Kidney Int . 2006 ; 69 ( 4 ): 760 - 4 .

Sorokin I , Mamoulakis C , Miyazawa K , Rodgers A , Talati J , Lotan Y . Epidemiology of stone disease across the world . World J Urol . 2017 ; 35 ( 9 ): 1301 - 20 .

Scales CD Jr , Tasian GE , Schwaderer AL , Goldfarb DS , Star RA , Kirkali Z . Urinary stone disease: advancing knowledge, patient care, and population health . Clin J Am Soc Nephrol . 2016 ; 11 ( 7 ): 1305 - 12 .

Egan KB . The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms: prevalence and incident rates . Urol Clin North Am . 2016 ; 43 ( 3 ): 289 - 97 .

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990–2019

Epidemiological trends of subarachnoid hemorrhage at global, regional, and national level: a trend analysis study from 1990 to 2021

Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021

Effect of early administration of tetracosactide on mortality and host response in critically ill patients requiring rescue surgery: a sensitivity analysis of the STOPSHOCK phase 3 randomized controlled trial

N-terminal pro-brain natriuretic peptide – a significant biomarker of disease development and adverse prognosis in patients with exertional heat stroke

Related Author

Shao-Hua He

Xie-Yuan Leng

Xiao-Feng Xu

Qiao Huang

Hong Weng

Lu-Yao Li

Xu-Hui Li

Dao-Jing Ming

Related Institution

Precision Medicine Centre, the Second People’s Hospital of Huaihua

the First School of Clinical Medicine, Anhui Medical University

Department of Urology, Xianyang Central Hospital

Department of Urology, the First Affiliated Hospital of Xi’an Jiaotong University

Institute of Urology, Wuhan University

⁰